Logo image of RMT

ROYCE MICRO-CAP TRUST INC (RMT) Stock Price, Forecast & Analysis

USA - NYSE:RMT - US7809151043

10.11 USD
-0.05 (-0.49%)
Last: 11/7/2025, 8:15:08 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RMT. RMT was compared to 0 industry peers in the Unkown industry. RMT may be in some trouble as it scores bad on both profitability and health. RMT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RMT was profitable.
In the past year RMT had a positive cash flow from operations.
RMT Yearly Net Income VS EBIT VS OCF VS FCFRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 7.16%
ROE 7.45%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RMT Yearly ROA, ROE, ROICRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 5 10

1.3 Margins

RMT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 746.21%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RMT Yearly Profit, Operating, Gross MarginsRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 200 400 600 800 1K

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for RMT has been increased compared to 1 year ago.
The debt/assets ratio for RMT has been reduced compared to a year ago.
RMT Yearly Shares OutstandingRMT Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M 50M
RMT Yearly Total Debt VS Total AssetsRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

RMT has an Altman-Z score of 14.77. This indicates that RMT is financially healthy and has little risk of bankruptcy at the moment.
RMT has a debt to FCF ratio of 4.84. This is a neutral value as RMT would need 4.84 years to pay back of all of its debts.
RMT has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.84
Altman-Z 14.77
ROIC/WACCN/A
WACCN/A
RMT Yearly LT Debt VS Equity VS FCFRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

RMT has a Current Ratio of 0.46. This is a bad value and indicates that RMT is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.46 indicates that RMT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
RMT Yearly Current Assets VS Current LiabilitesRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

RMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.04%.
Looking at the last year, RMT shows a very negative growth in Revenue. The Revenue has decreased by -26.03% in the last year.
EPS 1Y (TTM)-41.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.13%
Revenue 1Y (TTM)-26.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RMT Yearly Revenue VS EstimatesRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.80 indicates a correct valuation of RMT.
RMT is valuated cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.8
Fwd PE N/A
RMT Price Earnings VS Forward Price EarningsRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 128.74
EV/EBITDA N/A
RMT Per share dataRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

RMT has a Yearly Dividend Yield of 7.52%, which is a nice return.
RMT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 7.52%

5.2 History

RMT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
RMT Yearly Dividends per shareRMT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

RMT pays out 53.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.8%
EPS Next 2YN/A
EPS Next 3YN/A
RMT Yearly Income VS Free CF VS DividendRMT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 20M 40M 60M
RMT Dividend Payout.RMT Dividend Payout, showing the Payout Ratio.RMT Dividend Payout.PayoutRetained Earnings

More info and screens

ROYCE MICRO-CAP TRUST INC

NYSE:RMT (11/7/2025, 8:15:08 PM)

10.11

-0.05 (-0.49%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-26 2025-08-26
Earnings (Next)02-26 2026-02-26
Inst Owners33.72%
Inst Owner Change-2.84%
Ins Owners0.17%
Ins Owner Change-27.97%
Market Cap531.68M
Revenue(TTM)5.54M
Net Income(TTM)41.34M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 7.52%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP53.8%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date09-12 2025-09-12 (0.18)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.8
Fwd PE N/A
P/S 95.97
P/FCF 128.74
P/OCF 128.74
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)0.79
EY7.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY0.78%
OCF(TTM)0.08
OCFY0.78%
SpS0.11
BVpS10.55
TBVpS10.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.7
Profitability
Industry RankSector Rank
ROA 7.16%
ROE 7.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 746.21%
GM N/A
FCFM 74.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.84
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 9.99%
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 14.77
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-433.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.93%
OCF growth 3YN/A
OCF growth 5YN/A

ROYCE MICRO-CAP TRUST INC / RMT FAQ

What does RMT do?

Royce Micro-Cap Trust Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. Royce Micro-Cap Trust, Inc. (the Fund) is a diversified closed-end investment company. The Fund's investment objective is long-term growth of capital, which it seeks by investing primarily in equity securities of companies. The Fund primarily invests in micro-cap securities. The company normally invests at least 80% of its net assets, such as common stock and preferred stock. The Royce Investment Partners (Royce) is the Fund’s investment adviser.


What is the stock price of ROYCE MICRO-CAP TRUST INC today?

The current stock price of RMT is 10.11 USD. The price decreased by -0.49% in the last trading session.


What is the ChartMill rating of ROYCE MICRO-CAP TRUST INC stock?

RMT has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is RMT stock listed?

RMT stock is listed on the New York Stock Exchange, Inc. exchange.